A GLOBAL COLLABORATION FOR EQUITABLE ACCESS TO BIOTECHNOLOGY

Bench to Bedside: Developing Affordable Diagnostics

Wed 29 July, 14:00-15:00 GMT

Virtual symposium featuring talks on diagnostic devices, from research and development to implementation. Join breakout sessions with researchers from Africa, Asia, Latin America and beyond to continue discussions on quality assurance, device design, and more. Participate to share your experiences and join Reclone Network working groups.

BENCH TO BEDSIDE: DEVELOPING AFFORDABLE DIAGNOSTICS

Videos and documents from the symposium coming soon!
Time_(GMT) Session Speaker
13:45 Virtual room opens
14:00 Opening Remarks
Harnessing African indigenous biological resources to develop “Best-in-Class” biologics for diagnostics. Daniel Ndima, CapeBio, South Africa
14:15 Breakout Sessions
Tools for evaluating the reliability and activity of locally produced enzymes
Nadine Mowoh, MboaLab, Cameroon
Development of Rapid Diagnostic Tests to Meet the REASSURED Criteria
Dr Kevin Land, University of Pretoria, South Africa
Travelling hopefully: collecting data to satisfy the Regulators (in my country)
Dr Keith Moore, Ateneo de Manila University, Philippines
14:45 Closing Talk
Designing user-friendly diagnostics Dr Jacqueline Linnes, Purdue University, USA
15:00 Meeting Closes
Online room will be open for continued discussion

Programme

Daniel Ndima

Daniel Ndima is the CEO of CapeBio in South Africa. CapeBio develops and manufactures molecular biology reagents. Mr Ndima has a Bachelors degree in Biotechnology from the University of the Western Cape, Cape Town, and a Masters degree in Structural Biology from the University of Pretoria. Recently, CapeBio has been working on the development of Covid-19 test kits.

Harnessing African indigenous biological resources to develop “Best-in-Class” biologics for diagnostics.

Africa relies heavily on international imports of Biotech products. The African Biotech Industry can be ignited by existing indigenous biological resources. The un-tapped biological reserves are proving to play a pivotal role in the development of diagnostic tools and reagents. Intra-African Biotech research, IP generation and trade can contribute to global distribution of Biotech technologies emerging from the African continent.

Dr Jacqueline Linnes

Dr Jacqueline Linnes is an assistant professor of Biomedical Engineering at Purdue University. She holds a PhD in Bioengineering from the University of Washington, and completed postdoctoral training at Brigham and Women’s Hospital as well as at Boston University. Her research aims to develop technologies for point-of-care diagnostics. She has expertise in paper-based devices, global health, and user-centered design.

Reclone Symposium 1.0: Local Manufacturing of Reagents

 

10 June 2020

View talks from the previous symposium on YouTube!
 
Speaker Link to Presentation
Chiara Gandini, University of Cambridge, UK The Research in Diagnostics DNA Collection: an open source toolkit for production of enzymes for diagnostic research
Anibal Arce, Pontificia Universidad Catolica de Chile, Chile One-step RT-PCR from locally produced M-MLC + pfu-Sso7d
Alejandro Caro, AGROSAVIA, Colombia Optimization of a low-cost RNA extraction protocol for SARS-Cov2 based on magnetic beads
Ricardo Chavez, Scintia, Mexico ViroDet: a community effort on COVID-19 diagnostics for Mexico and Latin America
Cassi Henderson, University of Cambridge, UK Scaling up local manufacturing of reagents
Alejandro Nadra, University of Buenos Aires, Argentina Advances by ReClone Argentina
Thomas Graham, UC Berkeley, USA BEARMix - open-source master mix for 1-step RT-qPCR
Nadine Mowoh, MboaLab, Cameroon Quality Management Systems for enzyme production in Cameroon
Linda Kahl, SciScript and Beneficial Bio Biotechnology and the Public Domain: how to find out if technology is free and open